These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16231261

  • 1. Fluconazole prophylaxis in HIV disease, revisited.
    Bozzette SA.
    Clin Infect Dis; 2005 Nov 15; 41(10):1481-2. PubMed ID: 16231261
    [No Abstract] [Full Text] [Related]

  • 2. Fluconazole-resistant pseudomembranous oral candidiasis.
    Shetty K.
    Ann Pharmacother; 2006 May 15; 40(5):993. PubMed ID: 16638917
    [No Abstract] [Full Text] [Related]

  • 3. Oral candidiasis, switching and antifungal resistance.
    Blignaut E.
    SADJ; 2000 Dec 15; 55(12):694. PubMed ID: 12608245
    [No Abstract] [Full Text] [Related]

  • 4. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, AIDS Clinical Trials Group Study Team 323, Mycoses Study Group Study Team 40.
    Clin Infect Dis; 2005 Nov 15; 41(10):1473-80. PubMed ID: 16231260
    [Abstract] [Full Text] [Related]

  • 5. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
    Valdez H, Gripshover BM, Salata RA, Lederman MM.
    AIDS; 1998 Mar 26; 12(5):538. PubMed ID: 9543458
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between fluconazole dosage regimens and the emergence of fluconazole-resistant Candida albicans.
    Goetz MB.
    AIDS; 1996 Mar 26; 10(3):335-6. PubMed ID: 8882674
    [No Abstract] [Full Text] [Related]

  • 7. Candidiasis at ICAAC.
    Barr D, Smart T.
    GMHC Treat Issues; 1995 Oct 26; 9(10):13. PubMed ID: 11362914
    [Abstract] [Full Text] [Related]

  • 8. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F, Valencia E, Polo R, Moreno V, González-Lahoz JM.
    Rev Clin Esp; 1996 Dec 26; 196(12):878-9. PubMed ID: 9132869
    [No Abstract] [Full Text] [Related]

  • 9. Maintenance therapy of oropharyngeal candidiasis in HIV-infected patients with fluconazole.
    Esposito R, Castagna A, Uberti Foppa C.
    AIDS; 1990 Oct 26; 4(10):1033-4. PubMed ID: 2261119
    [No Abstract] [Full Text] [Related]

  • 10. Fluconazole resistant oral candidiasis in HIV-infected patients.
    Tumbarello M, Tacconelli E, Caldarola G, Morace G, Cauda R, Ortona L.
    Oral Dis; 1997 May 26; 3 Suppl 1():S110-2. PubMed ID: 9456668
    [Abstract] [Full Text] [Related]

  • 11. Fluconazole: a new option in the treatment of Candida mucositis and esophageal candidiasis.
    Garber GE.
    J Otolaryngol; 1992 Apr 26; 21(2):92-4. PubMed ID: 1583715
    [Abstract] [Full Text] [Related]

  • 12. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.
    Clin Infect Dis; 2008 Nov 15; 47(10):1270-6. PubMed ID: 18840077
    [Abstract] [Full Text] [Related]

  • 13. Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.
    Kairon R, Godbole S, Kulkarni S, Ghate M, Sane S, Mehendale S, Risbud A, Shrotri A, Bharucha K.
    Int J Infect Dis; 2004 Jul 15; 8(4):251-2. PubMed ID: 15234330
    [No Abstract] [Full Text] [Related]

  • 14. [For oral candidiasis and co. Fluconazole remains in the forefront].
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():90. PubMed ID: 15373066
    [No Abstract] [Full Text] [Related]

  • 15. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
    Agha-Hosseini F.
    Oral Dis; 2006 Jul 26; 12(4):434; author reply 434. PubMed ID: 16792733
    [No Abstract] [Full Text] [Related]

  • 16. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    Blignaut E, Botes ME, Nieman HL.
    SADJ; 1999 Dec 26; 54(12):605-8. PubMed ID: 16892568
    [Abstract] [Full Text] [Related]

  • 17. No resistance to fluconazole with short-term treatment for oral thursh.
    AIDS Patient Care STDS; 1996 Dec 26; 10(6):379. PubMed ID: 11361570
    [No Abstract] [Full Text] [Related]

  • 18. [Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
    Muñoz P, Moreno S, Garau X, López Bernaldo de Quirós JC, Berenguer J, More J, Bouza E.
    Enferm Infecc Microbiol Clin; 1990 Nov 26; 8(9):560-4. PubMed ID: 2099857
    [Abstract] [Full Text] [Related]

  • 19. [Fluconazole (Diflucan): its clinical spectrum and development].
    Espejo Martínez J, Alvarez Medina MP, Sánchez Morales S.
    Rev Clin Esp; 1997 Apr 26; 197 Suppl 1():86-93. PubMed ID: 9297211
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis.
    Arora U, Jagdev M, Jindal N.
    Indian J Med Microbiol; 2009 Apr 26; 27(2):174-5. PubMed ID: 19384052
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.